Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term SurvivorsJohnnie J Orozco, Phuong T Vo, Ted A Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantationLihua E Budde, Katherine A Guthrie, Brian G Till, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2020
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL RegistryAnthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbiditiesHesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic MalignanciesManuela Matesan, Darrell R Fisher, Roger Wong, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphomaSteven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Blood|March 31, 2021
Acalabrutinib in treatment-naive chronic lymphocytic leukemiaJohn C Byrd, Jennifer A Woyach, Richard R Furman, et al.
Pageof 22